These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 8227782)

  • 1. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Ellis SG; Cowley MJ; Whitlow PL; Vandormael M; Lincoff AM; DiSciascio G; Dean LS; Topol EJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1137-42. PubMed ID: 7897127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous transluminal coronary angioplasty of one major coronary artery when the contralateral vessel is occluded.
    Lafont A; Dimas AP; Grigera F; Pearce G; Webb M; Whitlow PL
    J Am Coll Cardiol; 1993 Nov; 22(5):1298-303. PubMed ID: 8227783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation. Implications for patient selection. The Multivessel Angioplasty Prognosis Study Group.
    Ellis SG; Cowley MJ; DiSciascio G; Deligonul U; Topol EJ; Bulle TM; Vandormael MG
    Circulation; 1991 Jun; 83(6):1905-14. PubMed ID: 2040043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%.
    O'Keefe JH; Allan JJ; McCallister BD; McConahay DR; Vacek JL; Piehler JM; Ligon R; Hartzler GO
    Am J Cardiol; 1993 Apr; 71(11):897-901. PubMed ID: 8465778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).
    Bourassa MG; Kip KE; Jacobs AK; Jones RH; Sopko G; Rosen AD; Sharaf BL; Schwartz L; Chaitman BR; Alderman EL; Holmes DR; Roubin GS; Detre KM; Frye RL
    J Am Coll Cardiol; 1999 May; 33(6):1627-36. PubMed ID: 10334434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI).
    Berger PB; Velianou JL; Aslanidou Vlachos H; Feit F; Jacobs AK; Faxon DP; Attubato M; Keller N; Stadius ML; Weiner BH; Williams DO; Detre KM;
    J Am Coll Cardiol; 2001 Nov; 38(5):1440-9. PubMed ID: 11691521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term prognosis in patients with single-vessel or double-vessel coronary artery disease: does successful revascularization achieved by coronary angioplasty improve late outcome?].
    Kawaharada T
    J Cardiol; 2003 Jul; 42(1):1-11. PubMed ID: 12892036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of patients undergoing multivessel coronary stent implantation.
    Mathew V; Rihal CS; Berger PB; Bell MR; Garratt KN; Holmes R
    Int J Cardiol; 1998 Mar; 64(1):1-7. PubMed ID: 9579810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?
    Bell MR; Bailey KR; Reeder GS; Lapeyre AC; Holmes DR
    J Am Coll Cardiol; 1990 Sep; 16(3):553-62. PubMed ID: 2387928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).
    Rodriguez A; Mele E; Peyregne E; Bullon F; Perez-Baliño N; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1996 Apr; 27(5):1178-84. PubMed ID: 8609339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degree of revascularization and outcome after multivessel coronary angioplasty.
    Faxon DP; Ghalilli K; Jacobs AK; Ruocco NA; Christellis EM; Kellett MA; Varrichione TR; Ryan TJ
    Am Heart J; 1992 Apr; 123(4 Pt 1):854-9. PubMed ID: 1549992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.
    Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW
    Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful multiple segment coronary angioplasty: effect of completeness of revascularization in single-vessel multilesions and multivessels.
    Samson M; Meester HJ; De Feyter PJ; Strauss B; Serruys PW
    Am Heart J; 1990 Jul; 120(1):1-12. PubMed ID: 2193492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization.
    Kloeter UC; Jander NG; Buser PT; Osswald S; Mueller-Brand J; Pfisterer ME
    Int J Cardiol; 2001 Jul; 79(2-3):197-205. PubMed ID: 11461742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease.
    Musci M; Loebe M; Wellnhofer E; Meyer R; Pasic M; Hummel M; Bocksch W; Grauhan O; Weng Y; Hetzer R
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):268-74. PubMed ID: 9885117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.